Pheochromocytoma

• 

  Subject Areas on Research

  • 5' flanking DNA sequences direct cell-specific expression of rat tyrosine hydroxylase. 
  • Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytomas. 
  • Activation of Gz attenuates Rap1-mediated differentiation of PC12 cells. 
  • Analysis of complex matrices functional in neuronal process extension using monoclonal antibodies in vitro and in vivo. 
  • Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients. 
  • Benign adrenal lesions mimicking malignancy on MR imaging: report of two cases. 
  • Cancer in pregnancy: a review of the literature. Part I. 
  • Current management of adrenal tumors. 
  • Deficiency of dopamine-beta-hydroxylase. A new mechanism for normotensive pheochromocytomas. 
  • Delayed autotransplantation of a solitary kidney facilitated by pump perfusion preservation. 
  • Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH. 
  • Detecting pheochromocytoma: defining the most sensitive test. 
  • Diagnosis and management of pheochromocytoma. 
  • Diagnosis of pheochromocytoma on physical examination. 
  • Diagnosis of secondary hypertension: an age-based approach. 
  • Early diagnosis and treatment of medullary thyroid carcinoma. 
  • Extra-adrenal pheochromocytoma: a cause of ureteral obstruction. 
  • Factors affecting the surgical approach and timing of bilateral adrenalectomy. 
  • G protein gamma subunits contain a 20-carbon isoprenoid. 
  • Genotype-phenotype correlations of pheochromocytoma in two large von Hippel-Lindau (VHL) type 2A kindreds with different missense mutations. 
  • Identification and cell type specificity of the tyrosine hydroxylase gene promoter. 
  • Imaging of pheochromocytoma in 2 dogs using p-[18F] fluorobenzylguanidine. 
  • Iodine 131-labeled metaiodobenzylguanidine scintigraphy and biochemical analyses in suspected pheochromocytoma. 
  • Isolation of two E-box binding factors that interact with the rat tyrosine hydroxylase enhancer. 
  • Laparoscopic adrenalectomy for pheochromocytoma. A comparison to aldosteronoma and incidentaloma. 
  • Long-Term Outcomes of 125 Patients With Metastatic Pheochromocytoma or Paraganglioma Treated With 131-I MIBG. 
  • MR evaluation of adrenal masses at 1.5 T. 
  • Molecular phenotype of simian virus 40 large T antigen-induced primitive neuroectodermal tumors in four different lines of transgenic mice. 
  • Patterns of Use and Short-Term Outcomes of Minimally Invasive Surgery for Malignant Pheochromocytoma: A Population-Level Study. 
  • Perioperative Management of Adrenalectomy and Inferior Vena Cava Reconstruction in a Patient With a Large, Malignant Pheochromocytoma With Vena Caval Extension. 
  • Pheochromocytoma complicated with cardiomyopathy after delivery--a case report and literature review. 
  • Pheochromocytoma presenting as fever of unknown origin. 
  • Platelet uptake of the pheochromocytoma-scanning agent 131I-meta-iodobenzylguanadine. 
  • Posterior optic nerve ischemic neuropathy in the setting of phenoxybenzamine therapy after uneventful spinal fusion. 
  • Predictors of hemodynamic instability during surgery for pheochromocytoma. 
  • Regulated expression of the tyrosine hydroxylase gene by epidermal growth factor. 
  • Regulation of tyrosine hydroxylase mRNA by glucocorticoid and cyclic AMP in a rat pheochromocytoma cell line. Isolation of a cDNA clone for tyrosine hydroxylase mRNA. 
  • Regulation of tyrosine hydroxylase mRNA by glucocorticoid and cyclic AMP in a rat pheochromocytoma cell line. Isolation of a cDNA clone for tyrosine hydroxylase mRNA. 
  • Surgery in patients with unsuspected pheochromocytomas. 
  • Surgical management of pheochromocytoma with the use of metyrosine. 
  • Symptomatic hypotension following the clonidine suppression test for pheochromocytoma. 
  • The impact of minimally invasive parathyroidectomy on the way endocrinologists treat primary hyperparathyroidism. 
  • Tissue-specific transcription of the rat tyrosine hydroxylase gene requires synergy between an AP-1 motif and an overlapping E box-containing dyad. 
  • Transcriptional regulation of the tyrosine hydroxylase gene by glucocorticoid and cyclic AMP. 
  • Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report.